Skip to content

Latent myofascial trigger points injection therapy for irritable bowel syndrome:a clinical trial

Latent myofascial trigger points injection therapy for irritable bowel syndrome:a clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050013
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with irritable bowel syndrome aged 18-60 who signed informed consent; 2. Patients with irritable bowel syndrome meet Rome IV criteria; 3. Symptoms have appeared for at least 6 months before diagnosis, and the following criteria have been met in the past three months; recurrent abdominal pain, with an average of at least 1 day/week in the past three months, combined with two or more of the following: (1) Abdominal pain is related to defecation; (2) The attack is accompanied by a change in the frequency of defecation; (3) The onset is accompanied by changes in stool characteristics.

Exclusion criteria

Exclusion criteria: 1. Accompanied by severe heart, lung, liver and kidney insufficiency; 2. There is a clearly known gastrointestinal disease or family history; 3. History of gastrointestinal surgery; 4. Gastrointestinal bleeding or blood in stool; 5. Unexplained weight loss; 6. Continuous fever; 7. The puncture site is ruptured; 8. Mental disorders cannot cooperate.

Design outcomes

Primary

MeasureTime frame
Irritable Bowel Syndrome Severity Score;

Secondary

MeasureTime frame
Irritable Bowel Syndrome Quality of Life Score;

Countries

China

Contacts

Public ContactQi Feng

Qilu Hospital of Shandong University

qifeng66321@sina.com+86 18560083756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026